E
Iovance Biotherapeutics, Inc. IOVA
$2.45 -$0.08-3.16% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -111.66M -116.16M -78.56M -83.54M -97.10M
Total Depreciation and Amortization 11.94M 11.07M 11.69M 11.15M 10.86M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 23.08M 19.03M 31.56M 26.74M 26.52M
Change in Net Operating Assets 9.19M -17.63M -37.98M -13.32M -38.71M
Cash from Operations -67.45M -103.69M -73.30M -58.97M -98.43M
Capital Expenditure -7.46M -6.21M -4.17M -2.29M -442.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- 0.00 0.00 0.00
Divestitures -- -- -- -- --
Other Investing Activities 21.30M 22.08M 27.85M -46.51M 40.66M
Cash from Investing 13.84M 15.87M 23.68M -48.80M 40.22M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 13.73M 148.96M 3.19M 48.23M 153.83M
Repurchase of Common Stock -504.00K -5.64M -880.00K -6.28M -1.00M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 13.23M 143.32M 2.31M 41.95M 152.83M
Foreign Exchange rate Adjustments 739.00K 508.00K -1.18M 1.25M -125.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -39.64M 56.00M -48.49M -64.57M 94.49M